Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Fapon Biopharma Announces FDA Approval of IND for FP008, a First-in-Class Immunotherapy for Solid Tumors 2025-02-28 16:39
CARsgen's Allogeneic CD19/CD20 CAR-T Therapy Administers First Dose in a Patient with Autoimmune Disease 2025-02-28 08:15
Ubie and Nucleus Genomics Partner to Enhance Access to Genetic Testing and Drive Early Screening for Improved Health Outcomes 2025-02-27 22:30
WuXi Biologics Again Passed GMP Inspection by Japan PMDA 2025-02-27 12:30
Lunit Announces Leadership Transition at Volpara: Craig Hadfield Appointed CEO 2025-02-26 22:00
Fosun Pharma Received NMPA Approval for Wan Ti Le (Tenapanor Hydrochloride Tablets) 2025-02-26 18:33
CARsgen Therapeutics Introduced Zhuhai SB Xinchuang to Accelerate Allogeneic CAR-T Cell Products Development in Mainland China 2025-02-25 21:00
SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate 2025-02-25 21:00
WuXi XDC and LigaChem Biosciences Strengthen Partnership with Expanded MOU to Accelerate ADC Development 2025-02-25 18:34
YolTech Therapeutics Announces Positive Clinical Data for YOLT-203, an In Vivo Gene Editing Therapy for Primary Hyperoxaluria Type 1 (PH1) 2025-02-25 16:15
BioCity Announces its selective Endothelin Type-A Receptor Antagonist, SC0062, Met the Primary Endpoint in Diabetic Kidney Disease (DKD) in a Phase 2 trial (2-SUCCEED) 2025-02-25 14:48
CStone Announces Publication of GEMSTONE-303 Study Results for Sugemalimab (Cejemly®) in JAMA 2025-02-25 12:10
Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs 2025-02-25 09:13
Visionary Holdings Navigates a New Era of Precision Medicine, Achieving Major Breakthroughs in Targeted Therapy 2025-02-24 22:00
Complete Genomics unveils DNBSEQ-T1+ and DNBSEQ-E25 Flash at AGBT 2025 General Meeting 2025-02-24 20:00
MGI Tech Closes Strategic Partnership with Oncoclínicas&Co to Contribute to Genomic Innovation in Oncological Health 2025-02-24 11:15
Chime Biologics Supports Mabgeek to Enter the U.S. Phase III Trials for MG-K10 2025-02-21 21:15
Bestqool Unveils Four-Wavelength Pro Series and Second-Gen Mobile Stand at Original Price 2025-02-21 01:09
FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA 2025-02-21 00:01
Harbour BioMed and Insilico Medicine Achieve Strategic Collaboration to Advance AI-Driven Antibody Discovery and Development 2025-02-20 15:31